TECH vs XFOR · P/E 65, rev $1.22B vs rev $6.5M
Bio-Techne Corp (TECH) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported XFOR revenue for 2025-12-31 was $6.5M. Net income was -$79.2M. Revenue was up 154.2% from 2024-12-31 to 2025-12-31. XFOR currently screens at market cap $382.0M.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the TECH and XFOR stock pages for the full models.
Not investment advice.